Stock Comparison
BSX vs MDT
Boston Scientific Corp and Medtronic PLC side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$65.74B
$103.66B
P/E (TTM)
18.5
21.7
Forward P/E
13.2
13.6
Price/Sales
3.2
2.9
Price/Book
2.5
2.1
EV/EBITDA
13.7
12.5
Dividend Yield
—
3.56%
Profitability
Net Margin
17.30%
13.20%
Operating Margin
20.60%
22.10%
Return on Equity
14.70%
9.84%
Return on Assets
6.07%
4.92%
Growth (YoY)
Revenue Growth
11.60%
9.90%
Earnings Growth
100.00%
18.30%
Price & Risk
Beta
0.6
0.6
52-Week High
$109.50
$103.76
52-Week Low
$43.89
$72.65
Analyst Target
$75.00
$98.00
Compare BSX and MDT your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.